These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 15119915

  • 1. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
    Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM.
    J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
    [Abstract] [Full Text] [Related]

  • 2. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF.
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [Abstract] [Full Text] [Related]

  • 3. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH, Watkin JG, Liu C, Wohlreich MM, Raskin J.
    BMC Psychiatry; 2005 Jan 04; 5():1. PubMed ID: 15631624
    [Abstract] [Full Text] [Related]

  • 4. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
    Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA.
    J Clin Psychiatry; 2002 Apr 04; 63(4):308-15. PubMed ID: 12000204
    [Abstract] [Full Text] [Related]

  • 5. Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.
    Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE.
    J Clin Psychiatry; 2006 May 04; 67(5):761-70. PubMed ID: 16841626
    [Abstract] [Full Text] [Related]

  • 6. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
    Brannan SK, Mallinckrodt CH, Detke MJ, Watkin JG, Tollefson GD.
    J Psychiatr Res; 2005 Mar 04; 39(2):161-72. PubMed ID: 15589564
    [Abstract] [Full Text] [Related]

  • 7. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM, Meyers AL, Sunderajan P, Montano CB, Kass E, Trivedi M, Wohlreich MM.
    Ann Clin Psychiatry; 2008 Mar 04; 20(4):187-93. PubMed ID: 19034749
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
    Brecht S, Courtecuisse C, Debieuvre C, Croenlein J, Desaiah D, Raskin J, Petit C, Demyttenaere K.
    J Clin Psychiatry; 2007 Nov 04; 68(11):1707-16. PubMed ID: 18052564
    [Abstract] [Full Text] [Related]

  • 9. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.
    J Clin Psychiatry; 2012 Jul 04; 73(7):984-91. PubMed ID: 22901348
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
    Raskin J, Wiltse CG, Siegal A, Sheikh J, Xu J, Dinkel JJ, Rotz BT, Mohs RC.
    Am J Psychiatry; 2007 Jun 04; 164(6):900-9. PubMed ID: 17541049
    [Abstract] [Full Text] [Related]

  • 11. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr 04; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 12. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 04; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 13. Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression.
    Shelton RC, Andorn AC, Mallinckrodt CH, Wohlreich MM, Raskin J, Watkin JG, Detke MJ.
    Int Clin Psychopharmacol; 2007 Nov 04; 22(6):348-55. PubMed ID: 17917553
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
    Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN.
    Depress Anxiety; 2008 Nov 04; 25(7):E1-11. PubMed ID: 17587217
    [Abstract] [Full Text] [Related]

  • 15. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
    Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.
    Int J Clin Pract; 2007 Aug 04; 61(8):1337-48. PubMed ID: 17627710
    [Abstract] [Full Text] [Related]

  • 16. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun 04; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 17. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo.
    Robinson M, Oakes TM, Raskin J, Liu P, Shoemaker S, Nelson JC.
    Am J Geriatr Psychiatry; 2014 Jan 04; 22(1):34-45. PubMed ID: 24314888
    [Abstract] [Full Text] [Related]

  • 18. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.
    Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA.
    J Psychiatr Res; 2002 Jan 04; 36(6):383-90. PubMed ID: 12393307
    [Abstract] [Full Text] [Related]

  • 19. Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain: a double-blind randomized study.
    Romera I, Pérez V, Menchón JM, Schacht A, Papen R, Neuhauser D, Abbar M, Picard H, Gilaberte I.
    J Affect Disord; 2012 Dec 20; 143(1-3):47-55. PubMed ID: 22858211
    [Abstract] [Full Text] [Related]

  • 20. The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder.
    Sheehan DV, Meyers AL, Prakash A, Robinson MJ, Swindle RW, Russell JM, Mallinckrodt CH.
    Curr Med Res Opin; 2008 Sep 20; 24(9):2457-66. PubMed ID: 18662492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.